Q2 likely a solid but uneventful quarter, with consensus leaning towards an upgrade to sales guidance. Fair value range reiterated and limited estimate changes.

21 Jul 2023
Q2 likely to be uneventful

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Q2 likely to be uneventful
- Published:
21 Jul 2023 -
Author:
ABGSC Healthcare Research | Morten Larsen | Benjamin Silverstone -
Pages:
8 -
Q2 likely a solid but uneventful quarter, with consensus leaning towards an upgrade to sales guidance. Fair value range reiterated and limited estimate changes.